SCHEMBL20813448

SCHEMBL20813448

COc1cc(OC)c2ncnc(I)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 3/20 0.41
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ NQO2 P16083 2/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ LCK P06239 3/20 0.37
▸ EGFR P00533 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ PDGFRB P09619 2/20 0.36
▸ PDE10A Q9Y233 2/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 2/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20813807 0.80 PDE5A (0.42) PDE5ACYP1A1CYP1B1NQO2KDM4E
SCHEMBL14671423 0.79 POLB (0.50) PDE5ACYP1A1CYP1B1KDM4ELCK
SCHEMBL24067435 0.77 PDE5A (0.41) PDE5ACYP1A1CYP1B1NQO2KDM4E
SCHEMBL24392339 0.76 ALDH1A1 (0.51) PDE5AKDM4ELCKEGFRALDH1A1
SCHEMBL24392237 0.76 PDE10A (0.41) PDE5ACYP1A1CYP1B1NQO2KDM4E
SCHEMBL20813844 0.73 HTR1A (0.49) PDE5ANQO2EGFRMEN1KMT2A
SCHEMBL20813846 0.71 MAPT (0.56) KDM4ELCKEGFRMAPTLMNA
Hydrochloric Acid SCHEMBL8377118 0.71 PDE1B (0.52) PDE5AKDM4ELCKEGFRMEN1
SCHEMBL10112980 0.71 CA12 (0.41) CYP1A1CYP1B1KDM4EMEN1KMT2A
SCHEMBL19933282 0.70 ENPP1 (0.53) LCKEGFRPDGFRBPDE10APDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327882-A2 ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER The Board of Trustees of the Leland Stanford Junior University (US) 2024-02-28 — — EP disclosed
WO-2023077083-A1 ENPP1 INHIBITORS AS INHIBITORS OF METASTASIS ANGARUS THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
WO-2021226136-A1 ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE ANGARUS THERAPEUTICS, INC. (US) 2021-11-11 — — WO disclosed
WO-2019051269-A1 ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2019-03-14 — — WO disclosed
Send feedback